Bronchoscopic Lung Volume Reduction For Pulmonary Emphysema: Preliminary Experience With Endobronchial Occluder

Bronchoscopic Lung Volume Reduction For Pulmonary Emphysema: Preliminary Experience With Endobronchial Occluder
复制标题

支气管镜肺减容术治疗肺气肿:支气管内封堵器的初步经验

DOI:
10.4187/respcare.02218
复制
发表时间:
2013-08
期刊:
影响因子:
2.5
通讯作者:
Li, Yan
Li, Yan
中科院分区:
医学4区
文献类型:
--
作者:
Song, Liqiang;Zhao, Feng;Ti, Xinyu;Chen, Weiqiang;Wang, Gaowen;Wu, Changgui;Li, Yan

文献摘要

参考文献

相似文献

目的:描述自膨式支气管内封堵器在支气管镜肺减容术中的应用以及36个月随访手术。方法:招募了23例重度肺气肿受试者,并接受了自膨式支气管内封堵器的柔性支气管镜置入。在1周、1个月、3个月、6个月、12个月、24个月和36个月时评估结局。通过肺功能检查、6分钟步行试验、呼吸困难评分、BODE(体重指数、气流阻塞、呼吸困难和运动能力)指数和St乔治呼吸问卷分析可行性、安全性和有效性。结果:将58个自膨式支气管内封堵器植入先前选择的23个肺叶。随访期间未发现移位。5例受试者发生咳嗽等术后并发症,6例受试者发生大叶性肺炎,均不位于任何阻塞节段。18例患者FEV 1较基线改善> 15%(P <0.001),平均首次起效时间为5.65 ± 1.51个月,平均最大起效时间为6.35 ± 3.08个月。FVC或残气量与TLC的比值未观察到显著变化。在24个月期间,22例受试者的6分钟步行距离、呼吸困难评分和St乔治呼吸问卷总分均有所改善,少数受试者持续改善至研究结束。平均基线BODE指数在随访期间有所改善,但在研究结束时没有改善。结论:这项初步研究表明,在支气管镜肺减容术中置入自膨式支气管内封堵器后,肺功能、6分钟步行距离、呼吸困难评分、BODE指数和生活质量均得到早期显著改善。它的放置也证明既容易又安全。然而,只有少数受试者的初始改善得以长期维持。
OBJECTIVE: To describe the self-expanding endobronchial occluder, as utilized in bronchoscopic lung volume reduction, with a 36 month follow-up procedure. METHODS: Twenty-three subjects with severe emphysema were recruited and underwent flexible bronchoscopic placement of self-expanding endobronchial occluders. Outcomes were assessed at 1 week, 1-month, 3-, 6-, 12-, 24-, and 36-month intervals. Feasibility, safety, and efficacy were analyzed by means of pulmonary function testing, 6-min walk test, dyspnea score, BODE (body mass index, air-flow obstruction, dyspnea, and exercise capacity) index, and St George's Respiratory Questionnaire. RESULTS: Fifty-eight self-expanding endobronchial occluders were implanted into 23 lobes previously selected. No displacement was found during the follow-up. Five subjects experienced postoperative complications of cough, and 6 subjects had lobar pneumonia, which were not located in any of the blocked segments. The FEV1 in 18 subjects was improved by > 15%, compared with baselines (P < .001), and the mean first efficacy time and maximal efficacy time were 5.65 ± 1.51 months and 6.35 ± 3.08 months, respectively. No significant changes were observed in FVC or the ratio of residual volume to TLC. The 6-min walk distance, dyspnea score, and St George's Respiratory Questionnaire total score were improved in 22 subjects over a 24-month period, and a minority of subjects continued to improve through to the end of the study. Mean baseline BODE index had improved during follow-up, but not at the study's conclusion. CONCLUSIONS: This preliminary study demonstrates early significant improvements in pulmonary function, 6-min walk distance, dyspnea score, BODE index, and quality of life after placement of the self-expanding endobronchial occluder in bronchoscopic lung volume reduction. Its placement also proved both easy and safe. However, the initial improvements were maintained long-term for only a minority of subjects.
DOI: 10.1111/j.1745-7599.2011.00602.x
发表时间: 2011-04
影响因子: --
作者:
C. Downs
通讯作者: C. Downs
DOI: 10.1513/pats.200707-085et
发表时间: 2008-05
期刊: Proceedings of the American Thoracic Society
影响因子: --
作者:
E. Ingenito;D. Wood;J. Utz
通讯作者: E. Ingenito;D. Wood;J. Utz
DOI: 10.1111/j.1440-1843.2010.01896.x
发表时间: 2011-01
期刊: Respirology
影响因子: 6.9
作者:
S. Kotecha;G. Westall;L. Holsworth;A. Pham;T. Williams;G. Snell
通讯作者: S. Kotecha;G. Westall;L. Holsworth;A. Pham;T. Williams;G. Snell
DOI: 10.1164/ajrccm.163.5.2101039
发表时间: 2001-04
影响因子: 24.7
作者:
R. Pauwels;A. Buist;P. Calverley;C. Jenkins;S. Hurd
通讯作者: R. Pauwels;A. Buist;P. Calverley;C. Jenkins;S. Hurd
DOI: 10.1097/00128594-200307000-00024
发表时间: 2007
期刊: --
影响因子: --
作者:
F. Venuta;E. Rendina;T. Giacomo;G. Coloni
通讯作者: F. Venuta;E. Rendina;T. Giacomo;G. Coloni